Related Experiment Video
Updated: Jul 9, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates
Kazuo Hatano1, Kaoru Matsuzaki, Yumie Sato
1Department of Infectious Diseases, Pharmacology Research Laboratories, Astellas Pharma Inc, Yodogawa-ku, Osaka, Japan. kazuo.hatano@jp.astellas.com
Abstract:
In vitro antimicrobial activity of telavancin, a rapidly bactericidal lipoglycopeptide, was evaluated against 1500 strains of MRSA recently isolated in Japan. Telavancin had potent activity, with MIC values that ranged from 0.12 microg/ml to 0.5 microg/ml and a MIC90 value of 0.5 microg/ml. The MIC90s of vancomycin and linezolid were 1.0microg/ml and 2 microg/ml, respectively. No vancomycin intermediate resistant or vancomycin-resistant MRSAs were detected in this surveillance study.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Development of Antibiotic Resistance